Showing results (61-70 of 75) with videos related to
Sort By:
Pageof 8
Scientific Reports|October 5, 2022
Role of non-invasive methods in detecting liver impairment in familial Mediterranean fever adult patients with persistent hepatic cytolysisSamuel Deshayes, Thibault Fraisse, Soraya Fellahi, et al.BMC Gastroenterology|April 24, 2010
Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest)Thierry Poynard, Pascal Lebray, Patrick Ingiliz, et al.European Journal of Gastroenterology & Hepatology|December 3, 2019
Performance of liver biomarkers, in patients at risk of nonalcoholic steato-hepatitis, according to presence of type-2 diabetesThierry Poynard, Valentina Peta, Olivier Deckmyn, et al.Journal of Hepatology|May 29, 2013
Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis CThierry Poynard, Joseph Moussalli, Mona Munteanu, et al.Alimentary Pharmacology & Therapeutics|October 19, 2018
Long-term prognostic value of the FibroTest in patients with non-alcoholic fatty liver disease, compared to chronic hepatitis C, B, and alcoholic liver diseaseMona Munteanu, Raluca Pais, Valentina Peta, et al.Plos One|July 4, 2008
An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral loadYen Ngo, Yves Benhamou, Vincent Thibault, et al.Journal of Hepatology|December 3, 2013
Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest™) and transient elastography (FibroScan®)Thierry Poynard, Julien Vergniol, Yen Ngo, et al.Frontiers in Genetics|November 22, 2019
Identification of an Endoglin Variant Associated With HCV-Related Liver Fibrosis Progression by Next-Generation SequencingFrédégonde About, Stéphanie Bibert, Emmanuelle Jouanguy, et al.Gut|July 1, 2010
Interferon gamma receptor 2 gene variants are associated with liver fibrosis in patients with chronic hepatitis C infectionBertrand Nalpas, Roubila Lavialle-Meziani, Sabine Plancoulaine, et al.Journal of Hepatology|November 9, 2010
FibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC³ programThierry Poynard, Mona Munteanu, Massimo Colombo, et al.Pageof 8